The result of the ProC Global assay is a risk factor for venous thromboembolism independent of its sensitivity for protein C pathway abnormalities. Results of a case-control study.

被引：0
|
作者：
Toulon, PA [1 ]
Perez, P [1 ]
机构：
[1] Hop Cochin, Hematol Lab, F-75674 Paris, France
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
170
引用
收藏
页码：42A / 43A
页数：2
相关论文
共 50 条
  • [31] High Altitude Is an Independent Risk Factor for Postoperative Symptomatic Venous Thromboembolism After Knee Arthroscopy: A Matched Case-Control Study of Medicare Patients
    Cancienne, Jourdan M.
    Diduch, David R.
    Werner, Brian C.
    ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY, 2017, 33 (02): : 422 - 427
  • [32] Venous thromboembolism (VTE) risk factors among nursing home residents: A population-based case-control study.
    Petterson, TM
    Leibson, CL
    Heit, JA
    Bailey, KR
    Melton, LJ
    BLOOD, 2004, 104 (11) : 714A - 714A
  • [33] Protein S levels and the risk of venous thrombosis: results from the MEGA case-control study
    Pintao, Maria Carolina
    Ribeiro, Daniel D.
    Bezemer, Irene D.
    Garcia, Andrea A.
    de Visser, Marieke C. H.
    Doggen, Carine J. M.
    Lijfering, Willem M.
    Reitsma, Pieter H.
    Rosendaal, Frits R.
    BLOOD, 2013, 122 (18) : 3210 - 3219
  • [34] Association of Gene-Gene Interactions with Venous Thromboembolism (VTE): A Pathway-Directed Candidate-Gene Case-Control Study.
    Heit, John A.
    Armasu, Sebastian M.
    Petterson, Tanya M.
    Rider, David N.
    Cunningham, Julie M.
    de Andrade, Mariza
    BLOOD, 2009, 114 (22) : 68 - 68
  • [35] C677T methylenetetrahydrofolate reductase gene polymorphism as a risk factor involved in venous thromboembolism: A population-based case-control study
    Yin, Guancheng
    Yan, Liqing
    Zhang, Zhifeng
    Chen, Kebiao
    Jin, Xing
    MOLECULAR MEDICINE REPORTS, 2012, 6 (06) : 1271 - 1275
  • [36] Activated partial thromboplastin time: results of a case-control study evaluating six commercial reagents in assessing the risk of venous thromboembolism
    Tripodi, A.
    Chantarangkul, V.
    Asti, D.
    Martinelli, I.
    Mannucci, P. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (06) : 1407 - 1409
  • [37] Factor V Leiden (R506Q) and risk of venous thromboembolism: a case-control study based on the Spanish population
    GarciaGala, JM
    Alvarez, V
    Pinto, CR
    Soto, I
    Urgelles, MF
    Menendez, MJ
    Carracedo, C
    LopezLarrea, C
    Coto, E
    CLINICAL GENETICS, 1997, 52 (04) : 206 - 210
  • [38] Intimate partner violence as a risk factor for venous thromboembolism in women on combined oral contraceptives: An international matched case-control study
    Chea, Mathias
    Bourguignon, Chloe
    Bouvier, Sylvie
    Nouvellon, Eva
    Laurent, Jeremy
    Perez-Martin, Antonia
    Mousty, Eve
    Ripart, Sylvie
    Nikolaeva, Mariya Gennadevna
    Khizroeva, Jamilya
    Bitsadze, Victoria
    Makatsariya, Alexander
    Gris, Jean-Christophe
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 122 : 47 - 53
  • [39] Antipsychotic drugs and risk of venous thromboembolism: nested case-control study (vol 341, pg c4245, 2010)
    Parker, Chris
    BMJ-BRITISH MEDICAL JOURNAL, 2011, 342
  • [40] Role of nonalcoholic steatohepatitis as a risk factor for intrahepatic cholangiocarcinoma and its role in patients' prognosis: A case-control study.
    De Lorenzo, Stefania
    Tovoli, Francesco
    Vasuri, Francesco
    Malvi, Deborah
    D'Errico, Antonietta
    Brandi, Giovanni
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
12345